First-trimester maternal factors and biomarker screening for preeclampsia. - Test2 - elhamkhani - TriplyDB

First-trimester maternal factors and biomarker screening for preeclampsia.

First-trimester maternal factors and biomarker screening for preeclampsia.

http://www.wikidata.org/entity/Q38207000

about

Current best practice in the management of hypertensive disorders in pregnancy Hypertensive disorders of pregnancy: what the physician needs to know First trimester screening of circulating C19MC microRNAs can predict subsequent onset of gestational hypertension.Inflammatory and Other Biomarkers: Role in Pathophysiology and Prediction of Gestational Diabetes Mellitus.Pregnancy Associated Plasma Protein-A and Placental Growth Factor in a Sub-Saharan African Population: A Nested Cross-Sectional Study.Perspectives, preferences and needs regarding early prediction of preeclampsia in Dutch pregnant women: a qualitative study.First trimester screening of circulating C19MC microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?The effects of progressive muscular relaxation and breathing control technique on blood pressure during pregnancy.Development and validation of a prediction model for gestational hypertension in a Ghanaian cohort.Noninvasive Prenatal Screening for Genetic Diseases Using Massively Parallel Sequencing of Maternal Plasma DNA Principles of first trimester screening in the age of non-invasive prenatal diagnosis: screening for other major defects and pregnancy complications.Angiogenic factors: Potential to change clinical practice in preeclampsia?Improved prediction of gestational hypertension by inclusion of placental growth factor and pregnancy associated plasma protein-a in a sample of Ghanaian women.Creating biobanks in low and middle-income countries to improve knowledge - The PREPARE initiative

P2860

Q26739585-892704B8-917A-465A-89DC-B2B82069C8F3 Q26746757-9BADC9F8-8513-419A-95ED-788728245E48 Q34702612-BF67259B-5D93-4921-91B9-C6A421645A17 Q35814036-9E2455C4-C3FF-4EF9-BC9A-328CC6A0AE24 Q36105745-9F7302D2-A4D6-44F3-9AFE-12480E7FCC6C Q36243237-A16ED966-882E-41A1-AFFD-1F1C47F02BE4 Q36275303-1A4FAE4B-7C4A-4E55-8387-6C207114B306 Q36357099-FC5301A6-95D4-4A48-AB2B-913000B76F9C Q36872477-278E466F-ECDE-4404-835C-4FB3B54AA32D Q37598265-767F1494-F292-4F15-8617-1FFB45032492 Q38549770-B3FE0F96-FCD6-49B3-BF44-D2FBBDDF0E63 Q39429807-B422FEAE-CF20-4EC3-A173-B41E50435B23 Q46301113-4421FF6B-04D9-4A87-9833-D8587FD89698 Q53697948-9DB12D37-50A6-4AAD-942C-4ACD5B940EDA Q57623976-F6E9DABA-71CE-4F4F-9866-11BC4F401AEE

P2860

First-trimester maternal factors and biomarker screening for preeclampsia.

http://www.wikidata.org/entity/Q38207000

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

First-trimester maternal factors and biomarker screening for preeclampsia.

@en

type

label

First-trimester maternal factors and biomarker screening for preeclampsia.

@en

prefLabel

First-trimester maternal factors and biomarker screening for preeclampsia.

@en

P1433

Q38207000-C54E3D8B-4064-4CF5-98F9-11C3B667C549

P1476

Q38207000-077E640D-F89D-4C63-857B-31B96EB9034E

P2093

Q38207000-8B9A8EA6-D609-47E0-8E51-27314ACAED59

P2860

Q38207000-09344E0C-A999-4F21-91E4-0123203FA250

Q38207000-0AEDB769-F8F9-4521-8190-BF954E1A5568

Q38207000-0C519529-59AB-4496-A1E3-A043B6583DB0

Q38207000-1072ED15-3703-4368-AAF7-EC4459AEDBFF

Q38207000-1A2199BE-0129-41B1-BA52-8C72FE0E13E1

Q38207000-236AD4EF-9A15-40EF-AE69-3D20B672A35A

Q38207000-264FC8EF-DC3E-4AA3-B599-F55C6593278D

Q38207000-2859DF73-5F29-4912-92C8-E4E674C4B2FB

Q38207000-28C6154F-AB4F-4600-9E15-8F5BFCE6032D

Q38207000-2B4EDB69-E499-4E66-BF80-910747C51BDE

P304

Q38207000-71821247-C7D8-4CF5-86B6-9AA92B59663E

P31

Q38207000-E0C288EE-0774-4E07-B514-976B72AEEE22

P356

Q38207000-DC46678D-7267-45B0-B348-B911CF163543

P433

Q38207000-9CBCC566-E3B4-4F76-973C-CA5EC5336B31

P478

Q38207000-86A6E424-EE94-428E-BE34-F8458ED20C35

P50

Q38207000-8002AC22-B2B2-446C-AC7E-D737EAB66B39

P577

Q38207000-7D6EA547-EE3A-4A52-BFEC-4EEAA03A9B76

P5875

Q38207000-4D5EC420-0008-4B71-884D-DA922E0BF06D

P698

Q38207000-CA2BC69D-6A6E-4380-BE05-BC43C948ACC5

P921

Q38207000-928097DB-3596-4A2C-8A14-793B1696BD8B

Q38207000-961521C3-C9DC-4C26-A6AB-998CFF6574B8

Q38207000-9B43BDD2-AC9D-433E-9329-C84B805EFE2D

P356

P1433

Prenatal Diagnosis

P1476

First-trimester maternal factors and biomarker screening for preeclampsia

@en

P2093

Kypros H Nicolaides

http://www.w3.org/2001/XMLSchema#string

P2860

The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A

Early Administration of Low-Dose Aspirin for the Prevention of Preterm and Term Preeclampsia: A Systematic Review and Meta-Analysis

A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

Accuracy of mean arterial pressure and blood pressure measurements in predicting pre-eclampsia: systematic review and meta-analysis

The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.

Can antenatal clinical and biochemical markers predict the development of severe preeclampsia?

Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study.

Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Associati

Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction.

P304

618-627

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PD.4397

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-05-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261924732

http://www.w3.org/2001/XMLSchema#string

P698

24764257

http://www.w3.org/2001/XMLSchema#string

P921

maternal health